WHO ICTRP trial
Treatment of skin cancer using ablative fractional laser and ingenol mebutate.
EUCTR2017-002843-14-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002843-14-DK |
|---|---|
| Public title | Treatment of skin cancer using ablative fractional laser and ingenol mebutate. |
| Scientific title | Investigations of local skin reactions and safety after combined treatment of basal cell carcinoma using ablative fractional laser and ingenol mebutate - an exloratory, prospective, open-label phase 2a trial. |
| Primary sponsor | Bispebjerg Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Denmark |
| Conditions | Safety and local skin reactions in patients with basal cell carcinoma after combined treatment of blative fractional laser and ingenol mebutate. MedDRA version: 20.0 Level: PT Classification code 10004146 Term: Basal cell carcinoma System… |
| Interventions | Trade Name: Picato (ingenol mebutate) Product Name: Picato Product Code: D06BX02 Pharmaceutical Form: Gel INN or Proposed INN: PICATO CAS Number: 75567-37-2 Current Sponsor code: PEP005 D06BX02 Other descriptive name: INGENOL MEBUTATE… |
| Registration date | Jul 21, 2017 |
| Target size | 30 |
| Secondary IDs | 0407 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: